CD19, Human (Inebilizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-CD19, Human (Inebilizumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD19, Human (Inebilizumab biosimilar) |
| Clone | Inebilizumab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG1 kappa |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | n/a |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human CD19 Recombinant Antibody (Inebilizumab). Inebilizumab, sold under the brand name Uplizna, is a medication for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults.The most common adverse reactions include urinary tract infection, headache, joint pain (arthralgia), nausea and back pain. |
| Immunogen | n/a |
| Other Names | Anti-CD19 Recombinant Antibody, Research Grade Inebilizumab, Anti-Human CD19 Recombinant Antibody(Inebilizumab), MEDI-551, Antibody Drug Analogues, Monoclonal Antibody, YR1374, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 1299440-37-1 |
| Catalog # | YR1374 |
| Price | please inquire |
| Order / More Info | CD19, Human (Inebilizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies